Isothiocyantaes, such as benzyl isothiocyanate and sulforaphene, efficiently reduce the survival of prostate and breast cancer cells, what is associated with the induction of ROS, disruption of mitochondrial membrane potential and downregulation of Bcl-2 protein (Lin et al. 2017; Pawlik et al. 2017). The gene discussed is BCL2; the disease is breast carcinoma.